4
Changes in Ownership
Acumen Pharmaceuticals, Inc. Filed Acc 0001209191-21-046030
Director bought 35,000 shares at $16.00 ($560,000)
- Director acquired 261,775 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stalfort John A III Director | 2021-07-06 | Conversion | +130,180 | 137,324 | D | ||
| Stalfort John A III Director | 2021-07-06 | Purchase | +35,000 | $16.00 | $560,000 | 172,324 | D |
| Stalfort John A III Director | 2021-07-06 | Conversion | +131,595 | 131,595 | I | ||
| Derivatives | |||||||
| Stalfort John A III Director | 2021-07-06 | Conversion · Series A-1 Preferred | −130,180 | 0 | D | ||
| Stalfort John A III Director | 2021-07-06 | Conversion · Series B Preferred | −131,595 | 0 | I | ||
| Open-market purchases · 35,000 sh · avg $16.00 · $560,000 | |||||||
Loading xslF345X03/doc4.xml…